Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...
Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...
First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results